Fidelity Investments
ENZY

Fidelity Investments’s Enzymotec Ltd ENZY Stock Holding History

Fidelity Investments’s Portfolio ENZY Stock Details ENZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-28,900
Closed -$331K – 2750
2017
Q3 		$331K Sell
28,900
-56,000
-66% -$553K ﹤0.01% 2519
2017
Q2 		$688K Hold
84,900
– – ﹤0.01% 2475
2017
Q1 		$747K Hold
84,900
– – ﹤0.01% 2485
2016
Q4 		$556K Hold
84,900
– – ﹤0.01% 2542
2016
Q3 		$594K Hold
84,900
– – ﹤0.01% 2525
2016
Q2 		$710K Hold
84,900
– – ﹤0.01% 2509
2016
Q1 		$767K Hold
84,900
– – ﹤0.01% 2510
2015
Q4 		$832K Hold
84,900
– – ﹤0.01% 2543
2015
Q3 		$768K Sell
84,900
-44,611
-34% -$398K ﹤0.01% 2553
2015
Q2 		$1.08M Sell
129,511
-783,093
-86% -$7.19M ﹤0.01% 2536
2015
Q1 		$6.57M Sell
912,604
-13,400
-1% -$94.8K ﹤0.01% 2146
2014
Q4 		$6.96M Buy
926,004
+163,736
+21% +$1.19M ﹤0.01% 2126
2014
Q3 		$5.09M Buy
762,268
+704,068
+1,210% +$7.59M ﹤0.01% 2221
2014
Q2 		$790K Buy
+58,200
New +$977K ﹤0.01% 2538
2014
Q1 		– Sell
-519,189
Closed -$14M – 2756
2013
Q4 		$14M Buy
+519,189
New +$12.3M ﹤0.01% 1848

Other funds holding ENZY

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
DG
Delek Group Herzliya, Israel $2.59B AUM 1.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
GH
GAM Holding Zurich, Switzerland $1.57B AUM 25.73% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
CRA
Circle Road Advisors New York $27.7M AUM 35.85% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments's ENZY Position: Q4 2017 in Review

Fidelity Investments sold out of Enzymotec Ltd (ENZY) in Q4 2017, closing a stake of 28,900 shares — an estimated $331K sold.

Fidelity Investments first reported a position in ENZY in Q4 2013 and held it in 15 quarters. The position peaked at $14M in Q4 2013. 37 funds tracked by Wall St. Rank hold ENZY as of Q4 2017.

  • Fidelity Investments reported no remaining Enzymotec Ltd position as of Q4 2017 after selling out during the quarter.
  • Fidelity Investments sold 28,900 Enzymotec Ltd shares in Q4 2017, an estimated $331K.
  • Fidelity Investments first reported a position in Enzymotec Ltd in Q4 2013 and held it in 15 quarters.
  • Fidelity Investments's Enzymotec Ltd position peaked at $14M in Q4 2013.
  • 37 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q4 2017.

Based on Fidelity Investments's 13F filing for Q4 2017, filed 12 Feb 2018.